The body's skin frontier and the challenges of wound healing: Keloids

Journal of the American Dental Association

Volumn 131, Issue 3, 2000, Pages 362-365

  Slavkin, Harold C ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH PROMOTOR;

FUNCTIONS OF THE SKIN AND ITS APPENDAGES; HUMAN; KELOID; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; WOUND HEALING;

GROWTH SUBSTANCES; HUMANS; KELOID; SKIN PHYSIOLOGY; WOUND HEALING;

EID: 0034146519     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2000.0180     Document Type: Article

References (26)

1. Baylor College of Medicine. Grand rounds archives. Available at "http://www.bcm.tmc. edu:80/oto/grand/101493.html". Accessed Dec. 1, 1999.
2. Doctor's guide to the Internet: phase II clinical trial of gamma interferon in keloids. Available at "http://www.pslgroup.com/ dg/190be.htm". Accessed Dec. 14, 1999.
3. Varga J, Kahari VM. Eosinophiliamyalgia syndrome, eosinophilic fasciitis, and related fibrosing disorders. Curr Opin Rheumatol 1997;9(6):562-70.
4. Medscape. Interferon injection may reduce keloid recurrence. Available at "http://respiratorycare.medscape.com/IMNG/ SkinAllergyNews/1998/v.29.n08/san2908.01. 03.html". Accessed Dec. 1, 1999.
5. Ueda K, Furuya E, Yasuda Y, Oba S, Tajima S. Keloids have continuous high metabolic activity. Plast Reconstr Surg 1999; 104(3):694-8.
6. Higgins PJ, Slack JK, Diegelmann RF, Staiano-Coico L. Differential regulation of PAI-1 gene expression in human fibroblasts predisposed to a fibrotic phenotype. Exp Cell Res 1999;248(2):634-42.
7. Tuan TL, Zhu JY, Sun B, Nichter LS, Nimni ME, Laug WE. Elevated levels of plasminogen activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J Invest Dermatol 1996;106(5):1007-11.
8. Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 1999;43(2): 179-84.
9. Polo M, Smith PD, Kim YJ, Wang X, Ko F, Robson MC. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics. Ann Plast Surg 1999;43(2):185-90.
10. Bettinger DA, Yager DR, Diegelmann RF, Cohen IK. The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 1996;98(5): 827-33.
11. Messadi DV, Le A, Berg S, Huang G, Zhuang W, Bertolami CN. Effect of TGF-beta 1 on PDGF receptors expression in human scar fibroblasts. Front Biosci 1998;15;3:A16-22.
12. Saed GM, Ladin D, Olson J, Han X, Hou Z, Fivenson D. Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. Arch Dermatol 1998;134(8):963-7.
13. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79(4):1283-316.
14. Igarashi A, Nashiro K, Kikuchi K, et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 1996;106(4):729-33.
15. Ma S, Chang WP, Fang RH. Measurement of radiation-induced DNA double-strand breaks in human diploid fibroblasts from keloid and normal skin by single-cell gel electrophoresis. Plast Reconstr Surg 1996;98(5):821-6.
16. Ashcroft GS, Yang S, Glick AB, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammation response. Nat Cel Biol 1999;1(5):260-6.
17. Ladin DA, Hou Z, Patel D, et al. p53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen 1998;6(1): 28-37.
18. Yoshimoto H, Ishihara H, Ohtsuru A, et al. Overexpression of insulin-like growth factor-1 (IGF-1) receptor and the invasiveness of cultured keloid fibroblasts. Am J Pathol 1999;154(3):883-9.
19. Sato M, Ishikawa O, Miyachi Y. Distinct patterns of collagen gene expression are seen in normal and keloid fibroblasts grown in three-dimensional culture. Br J Dermatol 1998;138(6):938-43.
20. Chowdri NA, Masarat M, Mattoo A, Darzi MA. Keloids and hypertrophie scars: results with intraoperative and serial postoperative corticosteroid injection therapy. Aust N Z J Surg 1999;69(9):655-9.
21. Rubin P, Soni A, Williams JP. The molecular and cellular biologic basis for the radiation treatment of benign proliferative diseases. Semin Radiat Oncol 1999;9(2): 203-14.
22. Berman B, Flores F. The treatment of hypertrophic scars and keloids. Eur J Dermatol 1998;8(8):591-5.
23. Berman B, Flores F. Comparison of a silicone gel-filled cushion and silicone gel sheeting for the treatment of hypertrophic or keloid scars. Dermatol Surg 1999;25(6):484-6.
24. Venugopal J, Ramakrishnan M, Habibullah CM, Babu M. The effect of the anti-allergic agent Avil on abnormal scar fibroblasts. Burns 1999;25(3):223-8.
25. Tamai H, Katoh O, Suzuki S, et al. Impact of tranilast on restenosis after coronary angioplasty: tranilast restenosis following angioplasty trial (TREAT). Am Heart J 1999;138(5 Pt 1):968-75.
26. Chau D, Mancoll JS, Lee S, et al. Tamoxifen downregulates TGF-beta production in keloid fibroblasts. Ann Plast Surg 1998;40(5):490-3.